Anne Wojcicki, former chief executive of 23andMe, won a bid to acquire the genetic testing company she founded in a second auction.

Anne Wojcicki's nonprofit, TTAM Research Institute, has received court approval to acquire 23andMe, the genetic testing ...

A bankruptcy court this week approved the $305 million sale of genetics testing firm 23andMe to a nonprofit organization led ...

Anne Wojcicki, the co-founder and former CEO of 23andMe MEHCQ-0.51%decrease; red down pointing triangle, is poised to regain control of the DNA-testing company after a nonprofit she controls ...

Anne Wojcicki's nonprofit, TTAM Research Institute, has received court approval to buy 23andMe — the genetic testing company she cofounded. The $305 million deal, which was approved on Friday, ...

Anne Wojcicki's winning bid to reclaim control of 23andMe doesn't necessarily end the fight over what happens to the DNA of 15 million people collected by the bankrupt consumer genomics company.

NEW YORK (AP) — Anne Wojcicki’s bid to buy 23andMe, the genetic testing company she cofounded nearly 20 years ago, has received the court greenlight. That means Wojcicki’s nonprofit TTAM ...

Beleaguered genetic testing company 23andMe announced Friday that it has reached an agreement to sell itself to a nonprofit led by the company’s co-founder and former CEO, Anne Wojcicki ...

But Wojcicki submitted a separate $305 million bid through TTAM and pushed to reopen the auction. TTAM is an acronym for the first letters of 23andMe, according to The Wall Street Journal.

Anne Wojcicki regains control of 23andMe, the company she co-founded and led as CEO, through her nonprofit TTAM with a $305 million bid at a bankruptcy auction.

Anne Wojcicki’s $305 million offer to reclaim 23andMe casts new light on the lives and legacies of the groundbreaking Wojcicki sisters.